Woburn Retirement System v. Salix Pharmaceuticals, Ltd. et al

  1. August 18, 2017

    Class Attys Score $44.6M In Fees In $210M Salix Settlement

    A New York federal judge on Friday signed off on $44.6 million in fees for attorneys who secured a $210 million settlement to end a proposed class action by Salix Pharmaceuticals Ltd. shareholders claiming the company misrepresented inventory levels to falsely inflate its stock price.

  2. June 20, 2017

    Salix Class Attys Seek $44.6M In Fees For $210M Settlement

    Attorneys who secured a tentative $210 million settlement to end a proposed class action by Salix Pharmaceuticals Ltd. shareholders claiming the company misrepresented inventory levels to falsely inflate its stock price asked a New York federal judge Monday for $44.6 million in fees.

  3. March 27, 2017

    Salix To Pay $210M To Settle Stock Inflation Class Action

    Shareholders in a proposed class action asked a New York federal court on Friday for preliminary approval of a $210 million settlement to end a lawsuit accusing Salix Pharmaceuticals Ltd. of inflating stock prices by knowingly misrepresenting the company's wholesale inventory levels.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!